HLS Therapeutics Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for HLS Therapeutics Inc. (HLTRF) is 130.53M

According to HLS Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 130.53M. This represents a change of -11.91% compared to the average of 148.17M of the last 4 quarters.

HLS Therapeutics Inc. (HLTRF) Historical Enterprise Value (quarterly & annually)

How has HLTRF Enterprise Value performed in the past?

The mean historical Enterprise Value of HLS Therapeutics Inc. over the last ten years is 307.15M. The current 130.53M Enterprise Value has changed 4.15% with respect to the historical average. Over the past ten years (40 quarters), HLTRF's Enterprise Value was at its highest in in the December 2019 quarter at 621.30M. The Enterprise Value was at its lowest in in the June 2016 quarter at -1231356.48.

HLS Therapeutics Inc. (HLTRF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of HLS Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HLS Therapeutics Inc. (HLTRF) Average Enterprise Value

How has HLTRF Enterprise Value performed in the past?

The current Enterprise Value of HLS Therapeutics Inc. (HLTRF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

HLS Therapeutics Inc. (HLTRF) Enterprise Value vs. Peers

How is HLTRF’s Enterprise Value compared to its peers?

HLS Therapeutics Inc.’s Enterprise Value is less than Jushi Holdings Inc. (355.65M), less than Orexo AB (publ) (358.47M), greater than Shield Therapeutics plc (110.34M), less than Ascend Wellness Holdings, Inc. (675.67M), less than Cannara Biotech Inc. (181.33M), less than Orexo AB (publ) (358.47M), greater than FamiCord AG (77.33M), less than Hofseth BioCare ASA (734.00M), greater than Lumos Diagnostics Holdings Limited (70.35M), less than Auxly Cannabis Group Inc. (292.05M),

Build a custom stock screener for HLS Therapeutics Inc. (HLTRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HLS Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HLS Therapeutics Inc. (HLTRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HLS Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.